UNH Stock Risk & Deep Value Analysis
UnitedHealth Group Inc
Healthcare • Healthcare Plans
DVR Score
out of 10
What You Need to Know About UNH Stock
We analyzed UnitedHealth Group Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran UNH through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.
UNH Risk Analysis & Red Flags
What Could Go Wrong
The biggest immediate risk is persistent pressure from Medicare Advantage utilization trends, which could increase the medical care ratio (reported at 83.9% in Q1 2026) and erode profit margins for the UnitedHealthcare segment, potentially leading to future earnings misses or downward revisions to the current FY2026 EPS guidance of >$18.25.
Risk Matrix
Overall
Moderate
Financial
Low
Market
Low
Competitive
Medium
Execution
Medium
Regulatory
High
Red Flags
- ⚠
CEO Patrick Hugh Conway sold 800 shares on 2026-04-23, which while a small amount, does not signal strong conviction for outsized returns.
- ⚠
Commentary highlights ongoing Medicare Advantage utilization and medical care ratio pressure, suggesting a continuous challenge to profitability in a key segment.
- ⚠
The current median analyst price target ($378.88-$390.00) is at or slightly above the current share price of $380.31, indicating limited perceived upside by professionals.
Upcoming Risk Events
- 📅
Q2 2026 Earnings Miss (estimated 2026-07-28): If EPS falls below the $4.94 consensus or full-year guidance is lowered, potentially due to persistent Medicare Advantage utilization pressure or higher medical care ratios, leading to a stock correction.
- 📅
Increased Regulatory Scrutiny/Fines (ongoing): New governmental investigations or substantial fines related to antitrust, data privacy, or billing practices, potentially impacting over $1B in revenue or leading to significant legal costs.
When to Reconsider
- 🚪
Exit if the reported medical care ratio consistently exceeds 85% for two consecutive quarters, signaling unsustainable cost trends.
- 🚪
Sell if full-year adjusted EPS guidance is revised downwards to below $17.00, indicating a significant deterioration in earnings power.
- 🚪
Exit if quarterly operating cash flow falls below $6.0 billion, suggesting a weakening of the core business's ability to generate cash.
Unlock UNH Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does UnitedHealth Group Inc (UNH) Do?
Market Cap
$346.09B
Sector
Healthcare
Industry
Healthcare Plans
Employees
400,000
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children's health insurance and health care programs; and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Visit UnitedHealth Group Inc WebsiteInvestment Thesis
If UnitedHealth Group continues its proven strategy of leveraging its integrated Optum health services with its UnitedHealthcare insurance segment to drive operational efficiencies, maintain dominant market share, and consistently deliver low-single-digit YoY revenue and mid-single-digit YoY EPS growth (as seen in Q1 2026), then it will generate steady, defensive returns for long-term investors, solidifying its position as a core portfolio holding, despite its mega-cap status precluding 10x growth potential.
Is UNH Stock Undervalued?
Unlock the full AI analysis for UNH
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
UNH Price Targets & Strategy
12-Month Target
$400.00
Bull Case
$460.00
Bear Case
$287.00
Valuation Basis
Based on 21.87x forward P/E applied to the highest analyst consensus FY26 EPS of $18.29 = $400.00
Entry Strategy
Dollar-cost average at current levels or on dips towards $350-$360, acknowledging its stable, long-term nature.
Exit Strategy
For long-term investors, hold for stable dividend income and modest capital appreciation. Consider trimming positions above $450; stop-loss around $300 if fundamental outlook deteriorates.
Portfolio Allocation
3-5% for a moderate risk tolerance, reflecting its defensive characteristics and stability rather than high growth.
Price Targets & Strategy
Sign up free to unlock price targets and entry/exit strategies
Is UNH Financially Healthy?
Valuation
P/E Ratio
28.74
Forward P/E
18.40
EV/EBITDA
14.27
PEG Ratio
1.51
Price/Book
4.84
Price/Sales
0.77
Profitability
Gross Margin
16.10%
Operating Margin
4.12%
Net Margin
2.68%
Return on Equity
12.40%
Revenue Growth
9.67%
EPS
$13.24
Balance Sheet
Current Ratio
0.89
Quick Ratio
0.67
Debt/Equity
0.83
Total Debt
$49.90B
Cash & Equivalents
$21.50B
Cash Flow
Operating Cash Flow
$8.91B
Free Cash Flow
$17.70B
EBITDA
$21.50B
Other
Beta (Volatility)
0.65
Dividend Yield
2.31%
Does UNH Have a Competitive Moat?
Sign in to unlockMoat Rating
🏰 Wide
Moat Trend
Stable
Moat Sources
4 Identified
UnitedHealth Group's moat is highly durable due to the immense scale required to compete in the complex US healthcare system, deep regulatory know-how, and high switching costs for employers, providers, and patients. The integrated Optum model further reinforces this by creating a closed-loop ecosystem for care delivery and services.
Moat Erosion Risks
- •Significant government policy changes (e.g., 'Medicare for All' proposals) that could alter market structure and revenue models.
- •Antitrust regulatory actions targeting its dominant market position in specific segments, potentially forcing divestitures or limiting future M&A.
- •Technological disruption from agile startups or major tech companies, though difficult to replicate UNH's scale and regulatory embeddedness.
UNH Competitive Moat Analysis
Sign up to see competitive advantages
UNH Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral (primarily institutional interest; not a prominent retail meme or growth stock)
Institutional Sentiment
Positive (high institutional ownership at 87.86%, 'Moderate Buy' consensus with recent target raises by UBS, Jefferies, Bernstein, Truist).
Insider Activity (Form 4)
CEO Patrick Hugh Conway sold 800 shares on 2026-04-23. No other insider activity (buy/sell) explicitly mentioned or quantified in the provided research.
Options Flow
Normal options activity (no specific unusual options flow data was provided in the research, implying typical market behavior).
Earnings Intelligence
Next Earnings
2026-07-28 (estimated for Q2 2026)
Surprise Probability
Medium (historically good track record, Q1 beat, but large base makes significant surprises harder)
Historical Earnings Pattern
Typically experiences modest positive stock price movement (2-5%) on earnings beats and guidance raises, as seen with Q1 2026 results. Conversely, misses or guidance cuts can lead to moderate sell-offs (3-7%).
Key Metrics to Watch
Competitive Position
Top Competitor
Elevance Health ($ELV)
Market Share Trend
Stable (dominant player in a mature market; maintaining significant share through integrated services and broad offerings).
Valuation vs Peers
Trading at a slight premium or in line with sector peers on forward P/E (~18-21x vs. sector averages), reflecting its market leadership, scale, and diversified business model.
Competitive Advantages
- •Massive Scale and Bargaining Power
- •Integrated Care Delivery Model (Optum)
- •Regulatory Expertise and Compliance Infrastructure
- •Extensive Data Analytics and Technology Capabilities
Market Intelligence
Sign up free to unlock sentiment, earnings intel, and peer analysis
What Could Drive UNH Stock Higher?
Near-Term (0-6 months)
- •Q2 2026 Earnings Report (estimated 2026-07-28): If actual EPS significantly exceeds the $4.94 consensus and full-year guidance is raised further, it could signal stronger-than-expected operational efficiency.
- •Medicare Advantage Enrollment Data (Q3/Q4 2026): Strong enrollment figures in the upcoming reporting periods would demonstrate continued market share strength despite utilization pressures.
Medium-Term (6-18 months)
- •Optum Health Services Growth (FY2027): If Optum's earnings from operations return to robust double-digit growth (e.g., >10% YoY, generating an additional $500M+ in quarterly operating income), it would validate the integrated care model.
- •Regulatory Clarity on Transfer Pricing (FY2027-FY2028): Resolution or favorable outcome on any outstanding IRS transfer pricing notices, mitigating potential litigation risks and financial penalties, could remove a cloud of uncertainty.
Long-Term (18+ months)
- •Successful Expansion into Value-Based Care Models (FY2029-FY2030): If UNH significantly expands its capitated and value-based care contracts, demonstrating improved health outcomes and cost efficiencies that capture an additional 1-2% of the US healthcare spend (approx. $40B+ in new annual revenue), it would cement long-term leadership.
- •Global Market Penetration (FY2030+): Strategic acquisitions or organic growth into 2-3 significant international healthcare markets, contributing an additional 5-10% to total revenue, would diversify risk and open new avenues for stable growth.
Catalysts & Growth Drivers
Sign up free to see growth catalysts
What's the Bull Case for UNH?
- ✓
Watch quarterly Optum earnings from operations growth rate — a return to >10% YoY would be highly positive for the growth thesis.
- ✓
Monitor the medical care ratio (MCR) trend for any sustained increase above 85% which would signal margin erosion.
- ✓
Track regulatory announcements, particularly concerning Medicare Advantage payment rates or antitrust reviews, for potential adverse impacts on revenue or operations.
Bull Case Analysis
Sign up free to see the bull case
Competing with UNH
See how UnitedHealth Group Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
UnitedHealth Group Inc UNH | $346.1B | 0.2 | 28.7 | $111.7B | 2.7% | 9.7% | |
AbbVie Inc ABBV | $381.1B | 0.1 | 104.8 | $15.0B | 5.8% | 9.5% | Compare → |
Johnson & Johnson JNJ | $557.1B | 1.0 | 26.5 | — | 21.8% | 7.9% | Compare → |
Eli Lilly and Co LLY | $965.0B | 0.5 | 52.6 | — | — | — | Compare → |
Pfizer Inc PFE | $146.4B | 4.0 | 19.5 | $62.6B | 11.8% | 1.4% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
How UnitedHealth Group Inc Makes Money
UnitedHealth Group operates as a diversified healthcare company in the United States, primarily generating revenue through two core segments: UnitedHealthcare and Optum. UnitedHealthcare offers a wide range of health benefit plans and services to individuals, employers, and government-sponsored programs like Medicare and Medicaid. Optum, its health services arm, provides pharmacy benefits management, care delivery through physician practices and urgent care centers, and health data analytics and technology services to a broad client base, including other healthcare payers and providers. The company profits by managing healthcare costs, processing claims, and delivering integrated care and services.
Read Full Business Model BreakdownFAQ
What is the DVR Score for UnitedHealth Group Inc (UNH)?
As of June 1, 2026, UnitedHealth Group Inc has a DVR Score of 0.2 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of UnitedHealth Group Inc?
UnitedHealth Group Inc's market capitalization is approximately $346.1B. The company operates in the Healthcare sector within the Healthcare Plans industry.
What ticker symbol does UnitedHealth Group Inc use?
UNH is the ticker symbol for UnitedHealth Group Inc. The company trades on the NYQ.
What is the risk level for UNH stock?
Our analysis rates UnitedHealth Group Inc's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of UNH?
UnitedHealth Group Inc currently has a price-to-earnings (P/E) ratio of 28.7. This is in line with broader market averages.
Does UnitedHealth Group Inc pay a dividend?
Yes, UnitedHealth Group Inc pays a dividend with a current yield of approximately 2.31%.
Is UnitedHealth Group Inc's revenue growing?
UnitedHealth Group Inc has reported revenue growth of 9.7%. The company is growing at a moderate pace.
Is UNH stock profitable?
UnitedHealth Group Inc has a profit margin of 2.7%. The company is profitable but margins are modest.
How often is the UNH DVR analysis updated?
Our AI-powered analysis of UnitedHealth Group Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on June 1, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for UNH (UnitedHealth Group Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.